As I travel throughout the country, I have the opportunity to visit withsome very productive urologists, and I have identified a list of traitsthey all have in common. As reimbursements are reduced and expenses rise,physicians look for ways to maintain their income. Practices that placean emphasis on practice efficiency will be more productive and have greaterincomes.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
FDA grants cretostimogene grenadenorepvec Breakthrough and Fast Track Designations for NMIBC
December 5th 2023The designations, which will expedite the development and regulatory review of cretostimogene grenadenorepvec in this setting, are supported by results from the phase 3 BOND-003 trial.